Cargando…
Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders
Pigmentary manifestations can represent an early clinical sign in children affected by Neurofibromatosis type 1 (NF1), Legius syndrome, and other neurocutaneous disorders. The differential molecular diagnosis of these pathologies is a challenge that can now be met by combining next generation sequen...
Autores principales: | Giugliano, Teresa, Santoro, Claudia, Torella, Annalaura, Del Vecchio Blanco, Francesca, Grandone, Anna, Onore, Maria Elena, Melone, Mariarosa Anna Beatrice, Straccia, Giulia, Melis, Daniela, Piccolo, Vincenzo, Limongelli, Giuseppe, Buono, Salvatore, Perrotta, Silverio, Nigro, Vincenzo, Piluso, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722641/ https://www.ncbi.nlm.nih.gov/pubmed/31370276 http://dx.doi.org/10.3390/genes10080580 |
Ejemplares similares
-
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1
por: Santoro, Claudia, et al.
Publicado: (2018) -
A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report
por: Santoro, Claudia, et al.
Publicado: (2020) -
Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype–Phenotype Correlations
por: Peduto, Cristina, et al.
Publicado: (2023) -
Linked-Read Whole Genome Sequencing Solves a Double DMD Gene Rearrangement
por: Onore, Maria Elena, et al.
Publicado: (2021) -
Legius Syndrome and its Relationship with Neurofibromatosis Type 1
por: DENAYER, Ellen, et al.
Publicado: (2020)